Venerdì 18 Aprile 2025
Aggiornato: 23:17
10 ultim'ora clock BREAKING NEWS

CHIMICA E FARMACEUTICA

comunicato stampa

Epitomee® Announces Successful Completion of Pivotal Clinical Trial for Innovative Weight Loss Capsule

CAESAREA, Israel, Jan. 16, 2024 /PRNewswire/ -- Epitomee® announces the successful completion of the RESET pivotal clinical trial, for its weight loss capsule. The randomized placebo controlled, double blind trial, investigated the safety and efficacy of Epitomee® capsule versus the sham capsule control, alongside lifestyle interventions, for reducing body weight, in overweight or obese adults, with BMI of 27-40 without comorbidities, The trial was conducted in 9 different centers across the Unit...

comunicato stampa

Fermion announces IND Approval of Non-Addictive Pain Relief Drug FZ008-145 by China NMPA

GUANGZHOU, China, Jan. 10, 2024 /PRNewswire/ -- Guangzhou Fermion Technology Co., Ltd. (Fermion), a clinical-stage AI-based drug discovery company that specializes in developing drugs for autoimmune diseases and pain, has announced today that China National Medical Products Administration (NMPA) approved the Investigational New Drug (IND) application for its non-addictive pain relief drug FZ008-145.

Dr. Wolff’s Vagisan introduces hormone-free Moisturising Cream and Moisturising Cremolum, clinically proven to soothe vaginal dryness

Dr. Wolff’s Vagisan introduces hormone-free Moisturising Cream and Moisturising Cremolum, clinically proven to soothe vaginal dryness

HONG KONG SAR - Media OutReach - 18 October 2023 - Many woman experiencing menopause are troubled by vaginal dryness. It can cause discomfort when sitting, standing, exercising, during urinating and even working, and can greatly impact their quality of life. In Hong Kong, every 2 out of 3 women has experienced symptoms of Vaginal Dryness1. Yet, it remains a taboo topic, making it difficult for women to discuss their intimate health concerns with family, friends, or doctors, resulting in only one-...

comunicato stampa

SUANFARMA announces a collaboration with Reyoung Pharmaceutical to expand the existing portfolio of anti-infective and antibacterial products

MADRID, Oct. 18, 2023/PRNewswire/ -- SUANFARMA, through its R&D division, celebrates the historic agreement reached with Reyoung Pharmaceutical, a leader in the manufacture of active ingredients since 1966. Reyoung´s decades of experience as an exporter of products worldwide are perfectly aligned with SUANFARMA, which has been present in the pharmaceutical and nutritional ingredients market for 30 years.

Panel made in Italy Allegrini

Al SIA di Rimini si discute di investimenti e Made in Italy nell’Arena Allegrini

Milano, 17 ottobre 2023 – Il Gruppo Allegrini, storica azienda italiana attiva nel settore chimico con un’ampia gamma di produzioni nella detergenza professionale e nella cosmetica per l’hotellerie, nei giorni di presenza al SIA Hospitality Design 2023 di Rimini ha organizzato una serie di incontri con la presenza di importanti partner, che si sono tenuti presso l’ormai nota Arena Allegrini.

Steriline - Isolatori e Robotica al centro della filosofia zero sprechi

Steriline al CPhI di Barcellona 2023 con la RVCM2 “zero sprechi”

Como 10/10/2023 - Steriline sarà presente all’annuale edizione del CPhI, quest’anno a Barcellona, in programma tra il 24 e il 26 ottobre. L’occasione è ideale per riaffermare ancora una volta la filosofia "zero sprechi" che da anni alimenta gli investimenti in ricerca e sviluppo di nuovi prodotti dell’azienda comasca, leader nel settore del confezionamento primario per l’industria farmaceutica.

comunicato stampa

Endotronix Receives IDE Approval for the Market Expanding PROACTIVE-HF 2 Clinical Trial

NAPERVILLE, Ill., Oct. 9, 2023 /PRNewswire/ -- Endotronix, Inc., a digital health and medical technology company dedicated to advancing the treatment of heart failure (HF), announced it has received Investigational Device Exemption (IDE) approval from the FDA for a subsequent multicenter study, PROACTIVE-HF 2, which will evaluate the company's Cordella Sensor for pulmonary artery (PA) pressure-guided therapy. The prospective, dual-arm trial aims to expand access to New York Heart Association (NYH...



SEGUICI SUI SOCIAL

threads whatsapp linkedin twitter youtube facebook instagram

ora in
Prima pagina
articoli
in Evidenza